MUC5B and idiopathic pulmonary fibrosis: The fact that mucin in turn can block the adverse effects of salt (Travis et al., 1999) may explain why IPF patients with a common risk polymorphism in MUC5B, associated with increased mucin production, have significantly improved survival (Peljto et al., 2013).